The Wolfson Research Institute for Health and Wellbeing, established in 2001, is a major interdisciplinary unit within Durham University that fosters research on human health and wellbeing in both developed and developing countries.
We do this through our Challenge Academies. Each has been carefully built to address local and global unmet need in health-related issues. Closely aligned with the Sustainable Development Goals, these Academies have the interdisciplinary approach unique to Durham University built in. In this way, each Academy can address major problems in health and wellbeing, but also be responsive to new challenges as they arise.
We help our Challenge Academies grow, fostering networking, identifying and assisting with funding opportunities, expanding their internationalisation and ensuring impact through clinical, industry or policy collaboration. This approach is central to our core ethos where our Academies address the beginning (identifying the correct question), the middle (understanding who the problem affects and how) and the end (how we can use this knowledge to create purpose built solutions that don’t just help some of the people some of the time but all of the people, all of the time.
Building on the positive clinical and safety data from its lead drug nomacopan, Akari is developing a second related therapeutic candidate (votucalis) focusing on new clinical targets. Votucalis captures histamine and thereby has the unique potential to prevent activation of all four histamine G-protein coupled receptors (GPCRs) which can induce diverse pathophysiological processes, including chronic pain, itch and inflammation.
Find out more about the Wolfson Research Institute for Health and Wellbeing.
Durham University Queen's Campus University Boulevard Thornaby Stockton on Tees TS17 6BH
Tel: + 44 (0) 191 334 0013